Get ready for the next generation female intermittent catheter

female catheter with Micro-hole Zone Technology

A new standard for female intermittent catheterization

Do you ever wonder if your bladder is fully emptied after using a catheter? Have you found yourself repositioning the catheter to make sure no urine is left behind? Or do you worry about the number of UTIs you have every year?

Get ready for the latest innovation in catheter technology for women! Coloplast's Micro Hole Zone Technology is here to set a new standard for bladder emptying¹ and reduce the risk of UTIs.²

Sign up to be the first to know more

First Name:

Last Name

Email address:

Phone number:

Street Address:

City:

State:

Zip Code:

Additional notes

When catheterizing, you may experience urine flow stops. This can happen even though your bladder is not completely empty.³

If urine is left in the bladder after catheterization, bacteria in the urine and bladder may quickly multiply⁴ and could potentially cause a UTI.³

Adjusting the catheter until the bladder is completely empty is important to help reduce your risk of UTIs³ – but with the next generation female intermittent catheter from Coloplast, you are able to avoid having to adjust the catheter.¹

89% of intermittent catheter users reposition their catheter during catheterization⁵ – what if you didn't have to?

Most conventional catheters have two eyelets and require you to to adjust the catheter to empty your bladder.

The new Micro Hole Zone Technology by Coloplast is designed to completely drain urine from your bladder without having to readjust or repositon the catheter.¹

A catheter designed to reduce the risk of UTIs

With its new micro-hole zone, our upcoming compact female intermittent catheter addresses more catheter-related UTI risk factors² than ever before.

With recyclable product container material⁶, it is purposefully designed with the user and environment in mind.

Learn about UTI risk factors and how to address them

Many factors can raise your risk of contracting a UTI.² Understanding the different factors can help you take measures to avoid UTIs. Be informed with our UTI risk factor quick guide.

Luja female ensured zero flow stops in 87% of catheterizations & <10 mL residual urine at first flow stop in 83% of catheterizations (RCTs, post-hoc, NCT05841004, n=73, & NCT05814211, n=82). Coloplast Data-on-File, 01/2024. Individual results may vary.
Kennelly M, Thiruchelvam N, Averbeck MA, et al. Adult neurogenic lower urinary tract dysfunction and intermittent catheterisation in a community setting: risk factors model for urinary tract infections. Adv Urol. 2019;2019:2757862. Study supported by Coloplast.
Vahr S. et al., Urethral intermittent catheterization in adults, Arnhem Netherlands, European Association of Urology (EAUN). 2024.
Forsyth, V.S. et al., Rapid Growth of Uropathogenic Escherichia coli during Human Urinary Tract Infection, mBio, 2018.9(2).
Islamoska et al., Risk factors UTI and QoL BAUN poster, 2022.
Product design, use and local waste management specifics may limit recyclability.

Prior to use, refer to product labeling for complete product instructions for use, contraindications, warnings and precautions.

Luja female is indicated for use by patients with urine retention and patients with a post void residual volume (PVR) due to neurogenic and non-neurogenic voiding dysfunction. The catheter is inserted into the urethra to reach the bladder allowing urine to drain. The product is indicated for female patients only (adults and children of and above the age of 2 years). Available by prescription only. Patients performing self-catheterization should follow the advice of, and direct questions about use of the product to, their medical professional. Apply with caution if the patient produces urine with many particles clearly distinguishable by the naked eye, as it may lead to transient urine retention. Before using the device, carefully read the product labels and information accompanying the device including the instructions for use which contain additional safety information. For single-use only; discard it after use. If you experience symptoms of a urinary tract infection, or are unable to pass the catheter into the bladder, contact your healthcare professional. The risk information provided here is not comprehensive. To learn more, talk to your healthcare provider. For further information, call Coloplast Corp. at 1-866-226-6362 and/or consult the company website www.coloplast.us.